Tonix Pharmaceuticals Holding Corp. (TNXP): Ernest Mario , director of Tonix Pharmaceuticals Holding Corp. purchased 31,042 shares on May 12, 2016. The Insider buying transaction was reported by the company on May 12, 2016 to the Securities and Exchange Commission. The shares were purchased at $2.30 per share for a total value of $71,356.24 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 11, 2016, Ernest Mario (director) purchased 8,210 shares at $2.24 per share price.On Mar 23, 2016, Seth Lederman (CEO) purchased 8,000 shares at $2.44 per share price.Also, On Oct 27, 2015, Gregory M Sullivan (Chief Medical Officer) purchased 5,000 shares at $5.18 per share price.On Sep 29, 2015, Leland Gershell (CFO) purchased 400 shares at $5.82 per share price.
Tonix Pharmaceuticals Holding Corp.: On Tuesday, May 10, 2016 heightened volatility was witnessed in Tonix Pharmaceuticals Holding Corp. which led to swings in the share price. The shares opened for trading at $2.18 and hit $2.3199 on the upside , eventually ending the session at $2.19, with a gain of 0.92% or 0.02 points. The heightened volatility saw the trading volume jump to 1,25,844 shares. The 52-week high of the share price is $10.72 and the company has a market cap of $41 M . The 52-week low of the share price is at $1.85.
Company has been under the radar of several Street Analysts.Tonix Pharmaceuticals Holding Corp. is Reiterated by Oppenheimer to Outperform while Lowering the Price Target of the company shares to $ 10 from a previous price target of $18 . The Rating was issued on Feb 17, 2016.